Long-term outcomes in antibody-negative autoimmune encephalitis: a retrospective study

2024-9-15

Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature review

2024-9-14

Correction to: Success rates of intensive aphasia therapy: real-world data from 448 patients between 2003 and 2020

2024-9-14

Cupulolithiatic BPPV involving both posterior semicircular canals: implications for set-point adaptation

2024-9-14

Genetic diagnosis of individuals at risk of CADASIL: prospect for future therapeutic development

2024-9-13

Leo G. Abood (1922–1998)

2024-9-13

Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review

2024-9-12

Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study

2024-9-12

Association between blood-based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: a systematic review

2024-9-12

Risks of epilepsy

2024-9-11

Takotsubo syndrome in a Sardinian amyotrophic lateral sclerosis cohort

2024-9-10

Jean Aicardi (1926–2015)

2024-9-10

GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)

2024-9-10

Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank

2024-9-9

Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease

2024-9-9

A multi-exon RFC1 deletion in a case of CANVAS: expanding the genetic mechanism of disease

2024-9-9

Rapid differentiation of MOGAD and MS after a single optic neuritis

2024-9-9

Neurofilament light chain as a diagnostic and prognostic biomarker in Guillain–Barré syndrome

2024-9-9

Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy

2024-9-6

Torsional saccadic palsy in episodic ataxia type 2

2024-9-6

Automated algorithms for seizure forecast: a systematic review and meta-analysis

2024-9-6

The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing–remitting multiple sclerosis

2024-9-6

Correction to: Fatigue in multiple sclerosis: can we measure it and can we treat it?

2024-9-6

Highly beneficial outcome in severe acute necrotizing encephalopathy with tocilizumab treatment

2024-9-6

Prevalence and motor-functional correlates of frontotemporal-spectrum disorders in a large cohort of non-demented ALS patients

2024-9-5

Exploring first-degree family history in a cohort of Portuguese Alzheimer’s disease patients: population evidence for X-chromosome linked and recessive inheritance of risk factors

2024-9-5

Correction to: Long-term vascular events after subarachnoid hemorrhage

2024-9-4

Mimickers of nervous system involvement among patients with Behçet’s syndrome

2024-9-4

Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study

2024-9-4

Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders

2024-9-4

Correction to: Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settings

2024-9-4

Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression

2024-9-4

Morris H. Aprison (1923–2007)

2024-9-4

Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas

2024-9-3

Diffusion tensor imaging and gray matter volumetry to evaluate cerebral remodeling processes after a pure motor stroke: a longitudinal study

2024-9-3

Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients

2024-9-3

Correction to: Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy

2024-9-3

Anti-sulfatide antibodies in neurological disorders: should we test?

2024-9-3

Assessment of the reliability, responsiveness, and meaningfulness of the scale for the assessment and rating of ataxia (SARA) for lysosomal storage disorders

2024-9-3

The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy

2024-9-2

Evolution from viral encephalitis to autoimmune encephalitis to multiple sclerosis: a case report

2024-8-31

Characteristics and outcomes of atrial fibrillation detected before and after acute ischemic stroke

2024-8-31

Biplanar MRI significantly improves early detection of transient global amnesia

2024-8-31

The dizzy patient: duration from symptom onset to specialist review

2024-8-30

Sparse item testing of clinical scales in neurology trials to alleviate burden to patients

2024-8-30

Therapeutic ancillary examinations in clinical neurology

2024-8-30

Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

2024-8-29

Anti-RGS8 paraneoplastic cerebellar ataxia is preferentially associated with a particular subtype of Hodgkin’s lymphoma

2024-8-29

Narrative review of diagnosis, management and treatment of dysphagia and sialorrhea in amyotrophic lateral sclerosis

2024-8-29

Does repetitive transcranial magnetic stimulation have a beneficial effect on improving unilateral spatial neglect caused by stroke? A meta-analysis

2024-8-28